Chronic Respiratory Diseases
12
3
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.4% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (12)
Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data
Retrospective Evaluation of the Implementation of a Digital Solution Supporting the Delivery of Pulmonary Rehabilitation Programs in Private Physiotherapy Practice
A Study to Evaluate the Diagnostic Performance of Portable Oscillometry Across Chronic Respiratory Diseases
Reference Equations and Normative Data for Isometric Quadriceps and Handgrip Muscles STrength in Southern European Populations - RESTart: a Multicentre Study
Belgian Lung Function Study
Chinese Population Health and Multimorbidity Study
Interest of Cryotherapy in Reducing Pain During Radial Arterial Blood Sampling
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
Intestinal Microbiota in COPD and Asthma
Evaluating the Relationship Between Environmental Risk Factors in Housing Types and Chronic Respiratory Diseases in Ho Chi Minh City
Phenotyping the Chronic Respiratory Diseases (CRD) in Ho Chi Minh City, Vietnam